Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Goldman Sachs Maintains Neutral Rating for LifeStance Health Gr: Here's What You Need To Know

Author: Benzinga Insights | November 22, 2023 01:00pm

Goldman Sachs has decided to maintain its Neutral rating of LifeStance Health Gr (NASDAQ:LFST) and lower its price target from $9.00 to $8.00.

Shares of LifeStance Health Gr are trading down 0.97% over the last 24 hours, at $6.10 per share.

A move to $8.00 would account for a 31.15% increase from the current share price.

About LifeStance Health Gr

LifeStance Health Group Inc is a provider of virtual and in-person outpatient mental health care for children, adolescents and adults experiencing a variety of mental health conditions.

About Analyst Ratings

Analysts work in banking and financial systems and typically specialize in reporting for stocks or defined sectors. Analysts may attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish "analyst ratings" for stocks. Analysts typically rate each stock once per quarter.

Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.

If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along with analyst success scores in Benzinga Pro.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: LFST

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist